Global Oncology Market Growth: As a global oncology company, BeOne Medicines' growth is significantly influenced by the increasing demand for cancer treatments, driven by an aging global population and advancements in precision medicine.

Regulatory Environment and Drug Approvals: The success of BeOne Medicines' pipeline and commercial products is highly dependent on favorable regulatory decisions and timely drug approvals, such as the FDA's Priority Review for sonrotoclax.

Competition and Pipeline Development: The highly competitive oncology market necessitates continuous innovation. BeOne's ability to maintain and grow market share relies on the ongoing success of its approved products like BRUKINSA and TEVIMBRA, and the successful development and commercialization of new therapies from its robust pipeline.